VERA - CIK 0001831828
The table below shows Vera Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $114.35M | $57.77M | $49.12M | $55.09M | $27.26M | $25.09M |
| Short-term investments | $482.41M | $439.62M | $507.71M | $534.74M | $326.05M | $359.30M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $615.80M |
| $511.31M |
| $571.35M |
| $606.08M |
| $364.13M |
| $394.75M |
| Property, plant & equipment | $945.00K | $1.16M | $1.15M | $1.06M | $368.00K | $155.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $621.74M | $517.50M | $578.53M | $610.17M | $368.56M | $397.29M |
| Accounts payable | $13.91M | $17.95M | $13.16M | $9.26M | $4.60M | $4.66M |
| Total current liabilities | $45.15M | $41.88M | $33.55M | $21.89M | $26.46M | $18.42M |
| Long-term debt | $75.03M | $74.65M | $74.46M | $50.91M | $50.47M | $50.26M |
| Total liabilities | $122.04M | $118.62M | $110.25M | $75.17M | $79.50M | $69.42M |
| Retained earnings | -$881.90M | -$669.77M | -$589.48M | -$512.94M | -$417.82M | -$371.19M |
| Total equity | $499.70M | $398.88M | $468.28M | $535.00M | $289.06M | $327.87M |